Giant Cell Arteritis (GCA)
Showing 1 - 25 of >10,000
Spatial Resolution of Several Contrast-enhanced 3D T1-WI
Not yet recruiting
- Giant Cell Arteritis
- 3D T1 MRI sequences injected with fat saturation and black blood
- (no location specified)
May 9, 2023
Giant Cell Arteritis, Polymyalgia Rheumatica Trial (Secukinumab)
Not yet recruiting
- Giant Cell Arteritis
- Polymyalgia Rheumatica
- (no location specified)
Nov 8, 2023
Giant Cell Arteritis Trial (Secukinumab 300 mg, s.c., Placebo to match Secukinumab, s.c.)
Recruiting
- Giant Cell Arteritis
- Secukinumab 300 mg, s.c.
- Placebo to match Secukinumab, s.c.
-
Berlin, Germany
- +2 more
Oct 12, 2022
Arteritis, Giant Cell Trial in Rochester (Baricitinib)
Completed
- Arteritis, Giant Cell
-
Rochester, MinnesotaMayo Clinic
Apr 7, 2022
Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis
Recruiting
- Polymyalgia Rheumatica (PMR)
- Giant Cell Arteritis (GCA)
- Data collection for cellular analyses (Immune subset composition, GCR expression, in vitro steroid responsiveness)
- +3 more
-
Basel, SwitzerlandDepartment of Rheumatology University Hospital Basel
Aug 2, 2022
Giant Cell Arteritis, Polymyalgia Rheumatica Trial
Not yet recruiting
- Giant Cell Arteritis
- Polymyalgia Rheumatica
- (no location specified)
Jun 28, 2023
Horton Disease Trial in Dijon (blood samples)
Recruiting
- Horton Disease
- blood samples
-
Dijon, FranceCHU Dijon Bourgogne
Sep 28, 2021
Giant Cell Arteritis Trial in Boston (Tocilizumab, Prednisone)
Recruiting
- Giant Cell Arteritis
-
Boston, MassachusettsMassachusetts General Hospital
Jul 23, 2021
Giant Cell Arteritis (GCA) Trial in Worldwide (Secukinumab 300 mg, Placebo)
Recruiting
- Giant Cell Arteritis (GCA)
- Secukinumab 300 mg
- +2 more
-
Fontana, California
- +83 more
Nov 10, 2022
Ultra-short Glucocorticosteroids and Tocilizumab Therapy in GCA
Active, not recruiting
- GCA
- +3 more
- Tocilizumab 162Mg/0.9Ml Autoinjector
-
Reggio Emilia, Emilia Romagna, ItalyAusl-Irccs - S.C. Di Reumatologia
May 26, 2022
Vessel Wall Enhancement in Giant Cell Arteritis
Recruiting
- Giant Cell Arteritis
- Magnetic Resonance Imaging (MRI)
-
Philadelphia, Pennsylvania3400 Civic Center Blvd
May 9, 2023
Giant Cell Arteritis, Optic Ischaemic Neuropathy Trial in France (tocilizumab and IV steroids combination, IV steroids
Recruiting
- Giant Cell Arteritis
- Optic Ischaemic Neuropathy
- tocilizumab and IV steroids combination
- IV steroids combination alone
-
Caen, France
- +9 more
Mar 3, 2022
Applanation Tonometry in the Diagnosis of Giant Cell Arteritis
Not yet recruiting
- Giant Cell Arteritis
- Applanation tonometry
-
Montreal, Quebec, CanadaVasculitis Clinic, Hopital du Sacre-Coeur de Montreal
Jan 26, 2023
Optic Nerve Sheath Ultrasound in Giant Cell Arteritis
Not yet recruiting
- Giant Cell Arteritis
- +2 more
- Optic nerve ultrasound
-
Joliette, Quebec, Canada
- +3 more
Feb 18, 2023
Vasculitis, Diagnoses Disease Trial in Würzburg (CXCR4-PET)
Recruiting
- Vasculitis
- Diagnoses Disease
- CXCR4-PET
-
Würzburg, Bayern, GermanyDepartement of Internal Medicine II, Rheumatology/Clinical Immun
Dec 4, 2022
Giant Cell Arteritis Trial in Nice
Completed
- Giant Cell Arteritis
-
Nice, Alpes-Maritimes, FranceHospital of the Archet
Jul 20, 2022
Study of Circulating Microparticles in Giant Cell Arteritis
Recruiting
- Giant Cell Arteritis
- Acute Phase
- Blood sample
-
Caen, FranceCentre Hospitalier Universitaire Côte de Nacre
Mar 8, 2022
Giant Cell Arteritis Trial in Dijon (drug, other, biological, procedure)
Not yet recruiting
- Giant Cell Arteritis
- Tocilizumab treatment
- +3 more
-
Dijon, FranceChu Dijon Bourgogne
Sep 7, 2023
Diabetes Mellitus in Giant Cell Arthritis and Polymyalgia
Recruiting
- Giant Cell Arteritis
- +2 more
-
Aalborg, Nordjylland, DenmarkAalborg University Hospital
Aug 21, 2023
PET Imaging of Giant Cell and Takayasu Arteritis
Active, not recruiting
- Giant Cell Arteritis
- Takayasu Arteritis
- PET-MRI
-
Cambridge, Cambridgeshire, United Kingdom
- +1 more
Jul 31, 2022
Individuals With Giant Cell Arteritis
Completed
- Temporal Arteritis
-
Boston, Massachusetts
- +8 more
Jul 11, 2022